Previous Article | Next Article 
Infection and Immunity, March 2000, p. 1183-1188, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Malaria Infection Induces Rapid Elevation of the
Soluble Fas Ligand Level in Serum and Subsequent T Lymphocytopenia:
Possible Factors Responsible for the Differences in Susceptibility of
Two Species of Macaca Monkeys to Plasmodium
coatneyi Infection
Jun
Matsumoto,1,*
Satoru
Kawai,1
Keiji
Terao,2
Masashi
Kirinoki,1
Yasuhiro
Yasutomi,3
Masamichi
Aikawa,4 and
Hajime
Matsuda1
Department of Medical Zoology, Dokkyo
University School of Medicine, Tochigi,1
Tsukuba Primate Center for Medical Sciences,
Ibaraki,2 Department of Bioregulation,
Mie University School of Medicine, Mie,3 and
Research Institute of Medical Sciences, Tokai University,
Kanagawa,4 Japan
Received 14 September 1999/Returned for modification 4 November
1999/Accepted 15 November 1999
 |
ABSTRACT |
The intraerythrocytic stage of the simian malaria parasite
Plasmodium coatneyi (CDC strain) was intravenously
inoculated into two species of macaques with different susceptibilities
to infection with this parasite, including four Japanese macaques
(Macaca fuscata) and three cynomolgus macaques (M. fascicularis). The Japanese macaques infected with P. coatneyi developed severe clinical manifestations similar to
those of severe human malaria and eventually became moribund, while the
infected cynomolgus macaques, natural hosts of the parasite, exhibited
no severe manifestation of disease except anemia and finally recovered
from the infection. In the infected Japanese macaques, peripheral
CD4+ and CD8+ T-cell populations were markedly
decreased and fragmentation of chromosomal DNA in peripheral blood
mononuclear cells was detected during the terminal period of infection,
suggesting that apoptotic cell death was responsible at least in part
for the T lymphocytopenia. Furthermore, soluble Fas ligand levels in
sera of the infected Japanese macaques increased gradually to a
markedly high level of 28.83 ± 10.56 pg/ml (n = 4) when the animals became moribund. On the other hand, none of the
infected cynomolgus monkeys exhibited either T lymphocytopenia or
elevated soluble Fas ligand level. These findings suggest that
differences in immune response between the two species of macaque
tested accounted for the contrasting outcomes after infection with the
same isolate of malarial parasite, and in particular that a profound T
lymphocytopenia due to Fas-derived apoptosis played a role in the fatal
course of malaria in the infected Japanese macaques.
 |
INTRODUCTION |
Plasmodium falciparum
infection leads to severe signs and symptoms and a wide variety of
clinical consequences, but not every patient becomes seriously ill or
dies (28). The outcome of infection is influenced by
individual susceptibility, parasite virulence, and a number of
environmental factors, and recent intensive studies on the factors
responsible for resistance to malarial infection have elucidated some
effects of host genetic background on outcome of infection as well
(8, 16).
P. coatneyi, a simian malarial parasite, causes mild
infection in its natural host, the cynomolgus macaque (Macaca
fascicularis) (4), but more serious infection in
experimental hosts such as the Japanese macaque (M. fuscata)
(11) and rhesus macaque (M. mulatta)
(1). In the latter two species, infected monkeys develop a
fulminating acute infection with pronounced parasitemia and became
moribund with severe manifestations. Furthermore, they exhibit
histopathological findings typical of cerebral malaria: sequestration
of parasitized red blood cells and cytoadherence-associated knobs on
parasitized red cells to endothelial cells were found in cerebral
microvessels and capillaries of major organs in these monkeys. Japanese
macaques and rhesus macaques infected with P. coatneyi can
thus be used as powerful primate models for the pathophysiological study of severe human malaria.
The Japanese macaque belongs to the genus Macaca, the same
genus as the rhesus macaque and cynomolgus macaque, and is found on
three of the four major islands of Japan (15), where natural infection with simian malaria has never been reported. On the other
hand, the cynomolgus macaque is widely distributed throughout Southeast
Asian countries (15), where various species of simian malaria are endemic and the monkey is a natural host of malarial parasites such as P. coatneyi, P. cynomolgi,
P. inui, and P. knowlesi (5). As
previously proposed (29), one important factor maintaining the species integrity of cynomolgus macaques may be ecological isolation due to genetic resistance to certain species of simian malarial infection.
In the present study, we used two species of macaques differing in
susceptibility to P. coatneyi infection, Japanese macaques and cynomolgus macaques, as models nonresistant and resistant to
malarial infection, respectively. The aim of this study was to clarify
immunological features in infected monkeys with different susceptibilities to the parasite. The infected Japanese macaques exhibited severe peripheral T lymphocytopenia and a markedly high serum
level of soluble Fas ligand (sFasL) when they became moribund, whereas
the infected cynomolgus macaques exhibited none of these changes.
We report here factors possibly determining the differences in outcome
between two species of macaques with different susceptibilities to
malaria infection and the applicability of the P. coatneyi-infected Japanese macaque to the pathophysiological study
of severe human malaria.
 |
MATERIALS AND METHODS |
Experimental animals.
Four Japanese macaques (J-8, J-9,
J-10, and J-11) and three cynomolgus macaques (CY-1, CY-2, and CY-3)
were used in this study in accordance with the guidelines for use of
experimental animals authorized by the Japanese Association for
Laboratory Animal Science. All monkeys were bred and grown in animal
facilities in a malaria-free environment in Japan and were 2 years old
when used. Each animal was kept in an individual cage in a controlled
environment at 25 to 29°C and fed commercial food pellets
supplemented with fresh fruits. At the time of infection, all animals
were clinically healthy and used without splenectomy.
Parasite and infection.
P. coatneyi (CDC strain) was
used in this study. This strain was also used in previous studies and
proved infective in macaques of both species employed in this study
(11, 14). Each macaque was intravenously inoculated with
108 blood-stage parasites that had been obtained from
another Japanese macaque infected with the parasite and cryopreserved
in liquid nitrogen until use.
Sample collection.
After inoculation, daily clinical
follow-up of the monkeys was performed; no antimalarial treatment was
given during the course of infection. For hematological examination and
flow cytometric analyses, venous blood samples were obtained every 3 or
4 days or more frequently after infection. When the infected macaques became moribund with high parasitemia, they were anesthetized with an
intramuscular injection of ketamine (15 mg/kg of body weight) and then
autopsied. Thin blood films were prepared from blood obtained through
earprick. Following Giemsa staining, parasitemia was counted in a total
of 104 erythrocytes under an optical microscope.
Flow cytometric analyses.
One or two-color immunophenotyping
was performed with monoclonal antibodies (MAbs) conjugated to
fluorescein isothiocyanate (FITC) or phycoerythrin (PE):
FITC-conjugated anti-human CD2, FITC-conjugated anti-human CD4
(Nichirei, Tokyo, Japan), FITC- or PE-conjugated anti-human CD20, FITC-
or PE-conjugated anti-human CD8 (Becton Dickinson, San Jose, Calif.),
and PE-conjugated anti-human CD95 (Pharmingen, San Diego, Calif.).
These MAbs had been screened in advance for reactivity against
lymphocytes of Macaca spp., including Japanese and
cynomolgus macaques. Blood samples were treated and stained with each
MAb according to the manufacturer's specifications. Briefly, 100 µl
of sample blood was mixed with 20 µl of MAb reagent and incubated for
15 min at room temperature. Cells were treated with buffer (FACS lysing
solution; Becton Dickinson), washed twice with phosphate-buffered
saline, resuspended in phosphate-buffered saline, and analyzed using
FACScalibur (Becton Dickinson). Analyses of the fluorescence
intensities were performed with CellQuest software (Becton Dickinson).
Samples were analyzed by setting appropriate forward and side scatter
gates around the lymphocyte population. The number of peripheral
leukocytes and their differential count were determined simultaneously.
The absolute count of lymphocytes for each subset was derived from the
number of circulating lymphocytes and the proportion of MAb-positive
cells in flow cytometric analyses. Fas-positive rates of
CD2+, CD4+, and CD8+ lymphocytes
were determined in two-color immunostaining using PE-labeled anti-CD95
MAb and FITC-labeled anti-CD2, anti-CD4, or anti-CD8 MoAb simultaneously.
DNA fragmentation assay.
To detect DNA fragmentation, which
is characteristic of cells undergoing apoptosis, fresh peripheral blood
mononuclear cells (PBMCs) were obtained from the infected Japanese
macaques and cynomolgus macaques, and PBMCs from an uninfected Japanese
macaque were used as a negative control. PBMCs were separated from
whole venous blood by Ficoll-Paque PLUS (Pharmacia Biotech AB, Uppsala, Sweden) density gradient, and 106 cells were treated as
described previously (18) prior to isolation of chromosomal
DNA. The DNA was then subjected to electrophoresis in a 0.75% agarose
gel and visualized with ethidium bromide.
Detection of sFasL in serum.
Serum sFasL levels in the
infected monkeys were measured using a commercially available human
sFasL-measuring kit (MBL, Nagoya, Japan), which is a sandwich
enzyme-linked immunosorbent assay system using two anti-human sFasL
hamster MAbs, 4H9 and 4A5 (20). The cross-reactivity of
monkey sFasL with these two MAbs had previously been demonstrated using
recombinant cynomolgus monkey sFasL (rCyFasL) that we had developed (Y. Kirii et al., submitted for publication). The measuring procedure was
basically as specified by the manufacturer except that rCyFasL was used
as a standard. One hundred microliters of either sample serum or
standard solution containing 5 to 1,000 pg of rCyFasL per ml was added
to two wells of primary antibody (4H9)-coated ELISA plate. After
reaction at room temperature for 1 h, the plate was washed five
times with washing solution. Then 100 µl of diluted
peroxidase-labeled secondary antibody (4A5) was added to each well and
reacted at room temperature for additional 1 h. After another five
washes, 100 µl of peroxidase substrate solution was added and allowed
to incubate at 37°C for 30 min. Finally, acid solution was added to
each well to terminate the enzyme reaction before the optical density
of each well was measured at 450 nm by a dual-wavelength plate reader
(THERMOmax, Molecular Devices, Sunnyvale, Calif.). The correlation
between optical densities and standard rCyFasL contents ranging from 5 to 1,000 pg/ml was always significant (r > 0.9, p < 0.01). Serum sFasL content was determined by reference to the
standard curve obtained from the reactivity of the rCyFasL.
 |
RESULTS |
Clinical findings and parasitemia.
In this study, two species
of Macaca monkeys, Japanese macaques and cynomolgus
macaques, had quite different consequences of infection with the same
isolate of the malarial parasite P. coatneyi: the infection
was fatal to the Japanese macaques, whereas the cynomolgus macaques
persisted with the infection and eventually survived. The infected
Japanese macaques were frequently anorectic, listless, and occasionally
depressed, and they finally became lethargic and severely withdrawn
just before autopsy on days 14 (J-8), 12 (J-9), 12 (J-10), and 11 (J-11) after infection. The parasite was first detected in the
peripheral blood of the infected Japanese macaques about 7 days after
infection; parasite densities then increased sharply to around 30%
within 2 weeks after infection (Fig. 1A).
Maximum parasitemias were 30.6% (J-8), 41.0% (J-9), 29.7% (J-10),
and 17.6% (J-11). On the other hand, the cynomolgus macaques exhibited
no severe manifestation except anemia (the lowest hematocrits were
18.0% [CY-1], 34.0% [CY-2], and 11.0% [CY-3]). The
prepatent period in the infected cynomolgus macaques was about 7 days;
parasitemia then increased, peaked at around 5%, and subsequently
decreased to less than 0.01% (Fig. 1B) within 35 days after infection.
Maximum parasitemias were 4.8% (CY-1), 0.2% (CY-2), and 11.0%
(CY-3).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Course of P. coatneyi parasitemia in four
Japanese macaques (A) and three cynomolgus macaques (B) after infection
with parasitized red blood cells.
|
|
Kinetics of lymphocyte subsets.
Absolute counts for each
lymphocyte subset at different time points in the infected macaques are
shown in Fig. 2 and
3. Of four P. coatneyi-infected Japanese macaques, three (J-8, J-9, and J-11)
had a markedly reduced number of CD2+ lymphocytes when they
were severely ill during the rapid increase in parasitemia (Fig. 2A).
None of the infected cynomolgus macaques exhibited reduced number of
CD2+ lymphocytes (Fig. 2B). The cynomolgus macaques instead
exhibited a gradual increase in CD2+ lymphocyte population
with one or two peaks just after infection and/or during the period in
which the peak of the parasitemia was observed. In the infected
Japanese macaques, differentiation of T-cell subsets by CD4 and CD8
markers revealed that the populations of both subsets had kinetics
similar to those of CD2+ lymphocytes (Fig. 3A) and thus
that both subtypes of lymphocytes were involved in T lymphocytopenia.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Absolute numbers of peripheral CD2+ ( )
and CD20+ ( ) lymphocytes in four Japanese macaques (A)
and three cynomolgus macaques (B) after infection with P. coatneyi.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of peripheral CD4+ ( ) and
CD8+ ( ) lymphocytes in four Japanese macaques (A) and
three cynomolgus macaques (B) after infection with P. coatneyi.
|
|
Involvement of apoptotic cell death in T lymphocytopenia.
We
hypothesized that T lymphocytopenia in P. coatneyi-infected
Japanese macaques was caused by apoptosis of T cells on the basis of
findings of previous studies of human malarial infection (24,
25). To confirm this hypothesis, chromosomal DNA was prepared
from fresh PBMCs of monkeys with or without P. coatneyi infection and analyzed by agarose gel electrophoresis. As shown in Fig.
4, DNA fragmentation occurred only in
PBMCs obtained from the P. coatneyi-infected Japanese
macaques when they became moribund, not in an uninfected control
monkey. In contrast, no ladder pattern of DNA fragments was observed on
electrophoresis using the samples from the infected cynomolgus macaques
on days 7, 14, and 21 after infection (data not shown).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 4.
Agarose gel electrophoresis of chromosomal DNA isolated
from PBMCs of Japanese macaques with (lane 1) or without (lane 2)
P. coatneyi infection. A sample from a parasite-infected
Japanese macaque (J-10) was obtained when the animal developed severe
signs of disease (12 days after infection). The positive control DNA
sample was isolated from PBMCs after incubation with an
apoptosis-inducing concentration (50 ng/ml) of recombinant sFasL for
24 h (lane 3). Lane M shows DNA molecular markers.
|
|
Rates of Fas expression of lymphocyte subsets.
Since Fas
antigen is a cell surface protein that mediates apoptosis, the
Fas-positive rate of each lymphocyte subset was determined before and
after infection with P. coatneyi (Table
1). In both species of macaques, Fas
positivity of CD2+ cells decreased on 11 to 14 days after
P. coatneyi infection, which was more pronounced in the
infected Japanese macaques when they became severely ill. In addition,
the Fas expression rate of CD4+ and CD8+ cells
also decreased in only Japanese macaques when they showed severe
manifestations.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Fas expression rates of each lymphocyte subset in
Japanese macaques and cynomolgus macaques before and after infection
with P. coatneyi
|
|
sFasL concentration in serum.
We subsequently measured sFasL
concentration in serum obtained from the infected monkeys. As clearly
shown in Fig. 5A, the infected Japanese
macaques had markedly increased levels of sFasL, and this elevation was
simultaneous with the period of T lymphocytopenia. The Japanese
macaques had high maximum levels of sFasL (17.38 pg/ml in J-8, 28.00 pg/ml in J-9, 42.94 pg/ml in J-10, and 27.00 pg/ml in J-11) at the time
of autopsy. In the cynomolgus macaques, which were free of T
lymphocytopenia, the concentration of serum sFasL remained much lower
than those in the infected Japanese macaques throughout the course of
infection (the highest concentrations were 3.69 pg/ml in CY-1, 7.11 pg/ml in CY-2, and 0.06 pg/ml in CY-3 [Fig. 5B]).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
Time course of serum sFasL levels in four Japanese
macaques (A) and three cynomolgus macaques (B) after infection with
P. coatneyi.
|
|
 |
DISCUSSION |
Host genetic factors including immune response which govern
susceptibility to malaria infection are well documented (8, 16). In the present study, two species of Macaca
monkeys exhibited markedly different outcomes of infection with the
same isolate of malaria parasite: infection was lethal to Japanese
macaques but not to cynomolgus macaques. These results were consistent with those described in previous reports (4, 11).
Studies of lymphocyte kinetics revealed that profound T lymphocytopenia
occurred in the P. coatneyi-infected Japanese macaques, whereas the infected cynomolgus macaques were free of T
lymphocytopenia. T lymphocytopenia is also a well-known finding for
human patients with acute severe malaria (3, 7, 9, 26), but
little is known concerning the changes in T-cell populations following infection with falciparum malaria. Our study of lymphocyte kinetics using a primate model of severe malaria revealed that T-cell numbers decreased most markedly when the infected Japanese macaques became moribund, suggesting that T lymphocytopenia was intimately associated with severe signs of disease.
Apoptosis is considered a possible mechanism of T lymphocytopenia in
human malaria, since patients with acute P. falciparum infection have higher in vitro percentages of lymphocyte apoptosis than
do healthy individuals (24, 25). To determine whether the T
lymphocytopenia observed in our study was also due to apoptosis, we
examined fragmentation of chromosomal DNA, one of the characteristics of cells undergoing apoptotic death. We found DNA fragmentation in
PBMCs of the infected Japanese macaques suffering from severe disease
but not in those of the infected cynomolgus macaques. These findings
support our hypothesis that apoptotic T-cell death was, at least in
part, responsible for peripheral T lymphocytopenia in the infected
Japanese macaques.
Fas is a membrane protein which mediates apoptosis when it is
cross-linked with its ligand. Fas-derived apoptosis plays roles in
physiological immune regulatory mechanisms (2, 6, 10), but
it can also be harmful (12) and even lethal (21).
To examine whether the apoptosis in the infected Japanese macaques was
mediated by Fas and its ligand, we measured both Fas expression rates
on the surface of lymphocytes and serum sFasL concentration. We found marked elevation of serum sFasL in nonresistant Japanese macaques, which was simultaneous with the decrease in the T-cell population. Interestingly, the resistant cynomolgus macaques, in which T
lymphocytopenia was absent, had outcomes very different from those of
the nonresistant Japanese macaques: in the former, the serum level of
sFasL remained very low throughout the course of infection. In
addition, we found that the Fas-positive CD2+,
CD4+, and CD8+ cell counts markedly decreased
just after the elevation of serum sFasL concentration only in the
infected Japanese macaques. These results strongly suggest that
Fas/FasL-mediated apoptosis involves the elimination of peripheral T
cells, resulting in severe lymphocytopenia and manifestations of
disease in the infected Japanese macaques. The difference in immune
responses including the function of FasL-producing cells during the
course of malaria infection might explain the difference in
susceptibility between Japanese macaques and cynomolgus macaques.
As described for other infectious diseases (13, 19, 23, 27),
falciparum malaria infection also induces host immune dysfunction
including a decreased number of circulating T cells (3, 7, 9,
26) and in vitro depression of proliferative response of PBMCs to
parasite antigens (17, 22), which may be responsible for the
severe disease of the patients with falciparum malaria. In fact, T
lymphocytopenia is also considered one of the typical features of human
acute falciparum malaria, and the degree of T lymphocytopenia is
correlated with disease severity: it is higher in patients with severe
malaria and those with cerebral malaria than in patients with
uncomplicated malaria (9). Although the pathogenic process
of severe malaria is considered multifactorial, our findings suggest
the additional possibility that malarial infection induces a high level
of sFasL in the periphery of nonresistant hosts, which causes T
lymphocytopenia and subsequent immune dysfunction and severe disease.
These immunopathological changes in severe malaria should be taken into
account in the design and analysis of cellular investigations and the
clinical treatment of patients with severe manifestations of falciparum malaria.
 |
ACKNOWLEDGMENTS |
We are grateful to W. E. Collins, Centers for Disease
Control and Prevention, for providing the parasite stock. We thank Shin Nippon Biomedical Laboratories, Ltd.; the New Drug Discovery Research Laboratory, Kanebo Ltd.; and Yasuko Nonaka for technical support.
This work was supported by Grant-in-Aid for Scientific Research on
Priority Areas 08281103 from the Ministry of Education, Science,
Culture and Sports, Japan, and the Japan-U.S. Medical Science Programme.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Zoology, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. Phone: (81) 282-87-2134. Fax: (81) 282-86-6431. E-mail: junmatsu{at}dokkyomed.ac.jp.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Aikawa, M.,
A. Brown,
C. D. Smith,
T. Tegoshi,
R. J. Howard,
T. H. Hasler,
Y. Ito,
G. Perry,
W. E. Collins, and K. Webster.
1992.
A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys.
Am. J. Trop. Med. Hyg.
46:391-397.
|
| 2.
|
Brunner, T.,
R. J. Mogil,
D. LaFace,
N. J. Yoo,
A. Mahboubi,
F. Echeverri,
S. T. Martin,
W. R. Force,
D. H. Lynch,
C. F. Ware, and D. R. Green.
1995.
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.
Nature
373:441-444[CrossRef][Medline].
|
| 3.
|
Chougnet, C.,
S. Tallet,
P. Ringwald, and P. Deloron.
1992.
Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum attack.
Clin. Exp. Immunol.
90:405-408[Medline].
|
| 4.
|
Coatney, G. R.,
W. E. Collins,
M. Warren, and P. G. Contacos.
1971.
The primate malarias, p. 289-299.
U.S. Government Printing Office, Washington, D.C.
|
| 5.
|
Eyles, D. E.
1963.
The species of simian malaria: taxonomy, morphology, life cycle, and geographical distribution of the monkey species.
J. Parasitol.
49:866-887[CrossRef][Medline].
|
| 6.
| Green, D. R., and D. W. Scott.
Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol.
6:476-487.
|
| 7.
|
Greenwood, B. M.,
A. J. Oduloju, and D. Stratton.
1977.
Lymphocyte changes in acute malaria.
Trans. R. Soc. Trop. Med. Hyg.
71:408-410[Medline].
|
| 8.
|
Hill, A. V. S.
1996.
Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome.
Parasitology
112(Suppl.):S75-S84.
|
| 9.
|
Hviid, L.,
J. A. L. Kurtzhals,
B. Q. Goka,
J. O. Oliver-Commey,
F. K. Nkrumah, and T. G. Theander.
1997.
Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria.
Infect. Immun.
65:4090-4093[Abstract].
|
| 10.
|
Ju, S.,
D. J. Panka,
H. Cui,
R. Ettinger,
M. El-Khatib,
D. H. Sherr,
B. Z. Stanger, and A. Marshak-Rothstein.
1995.
Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation.
Nature
373:444-448[CrossRef][Medline].
|
| 11.
|
Kawai, S.,
M. Aikawa,
S. Kano, and M. Suzuki.
1993.
A primate model for severe human malaria with cerebral involvement: Plasmodium coatneyi-infected Macaca fuscata.
Am. J. Trop. Med. Hyg.
48:630-636.
|
| 12.
|
Kondo, T.,
T. Suda,
H. Fukuyama,
M. Adachi, and S. Nagata.
1997.
Essential roles of the Fas ligand in the development of hepatitis.
Nat. Med.
3:409-413[CrossRef][Medline].
|
| 13.
|
Large, M. K.,
D. J. Kittlesen, and Y. S. Hahn.
1999.
Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
J. Immunol.
162:931-938[Abstract/Free Full Text].
|
| 14.
|
Migot-Nabias, F.,
B. Ollomo,
G. Dubreuil,
A. Morelli,
O. Domarle,
R. Nabias,
A. J. Georges, and P. Millet.
1999.
Plasmodium coatneyi: differential clinical and immune responses of two populations of Macaca fascicularis from different origins.
Exp. Parasitol.
91:30-39[Medline].
|
| 15.
|
Preston-Mafham, K., and R. Preston-Mafham.
1992.
Primates of the world, p. 61-83.
. Blandford Publishing, London, England.
|
| 16.
|
Riley, E. M.
1996.
The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens.
Parasitology
112(Suppl.):S39-S51.
|
| 17.
|
Riley, E. M.,
G. Andersson,
L. N. Otoo,
S. Jepsen, and B. M. Greenwood.
1988.
Cellular immune response to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria.
Clin. Exp. Immunol.
73:17-22[Medline].
|
| 18.
|
Sellins, K. S., and J. J. Cohen.
1987.
Gene induction by -irradiation leads to DNA fragmentation in lymphocytes.
J. Immunol.
139:3199-3206[Abstract].
|
| 19.
|
Sztein, M. B., and F. Kierszenbaum.
1993.
Mechanisms of development of immunosuppression during Trypanosoma infections.
Parasitol. Today
9:424-428[Medline].
|
| 20.
|
Tanaka, M.,
T. Suda,
K. Haze,
N. Nakamura,
K. Sato,
F. Kimura,
K. Motoyoshi,
M. Mizuki,
S. Tagawa,
S. Ohga,
K. Hatake,
A. H. Drummond, and S. Nagata.
1996.
Fas ligand in human serum.
Nat. Med.
2:317-322[CrossRef][Medline].
|
| 21.
|
Tanaka, M.,
T. Suda,
T. Yatomi,
N. Nakamura, and S. Nagata.
1997.
Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes.
J. Immunol.
158:2303-2309[Abstract].
|
| 22.
|
Theander, T. G.,
I. C. Bygbjerg,
B. J. Andersen,
S. Jepsen,
A. Kharazmi, and N. Odum.
1986.
Suppression of parasite specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition.
Scand. J. Immunol.
24:73-81[Medline].
|
| 23.
|
Tishon, A.,
M. Manchester,
F. Scheiflinger, and M. B. A. Oldstone.
1996.
A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs.
Nat. Med.
2:1250-1254[CrossRef][Medline].
|
| 24.
|
Toure-Balde, A.,
J. L. Sarthou,
G. Aribot,
P. Michel,
J. F. Trape,
C. Rogier, and C. Roussilhon.
1996.
Plasmodium falciparum induces apoptosis in human mononuclear cells.
Infect. Immun.
64:744-750[Abstract].
|
| 25.
|
Toure-Balde, A.,
J. L. Sarthou, and C. Roussilhon.
1995.
Acute Plasmodium falciparum infection is associated with increased percentages of apoptotic cells.
Immunol. Lett.
46:59-62[CrossRef][Medline].
|
| 26.
|
Troye-Blomberg, M.,
P. E. Sjöholm,
H. Perlmann,
M. E. Patarroyo, and P. Perlmann.
1983.
Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes.
Clin. Exp. Immunol.
53:335-344[Medline].
|
| 27.
|
Valentine, F. T.,
A. Paolino,
A. Saito, and R. S. Holzman.
1998.
Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease.
AIDS Res. Hum. Retroviruses
14(Suppl. 2):S161-S166.
|
| 28.
|
Warrell, D. A.
1993.
Clinical features of malaria, p. 35-49.
In
H. M. Gills, and D. A. Warrell (ed.), Bruce-Chwatt's essential malariology, 3rd ed. Edward Arnold, London, England.
|
| 29.
|
Wheatley, B. P.
1980.
Malaria as a possible selective factor in the speciation of macaques.
J. Mamm.
61:307-311[Medline].
|
Infection and Immunity, March 2000, p. 1183-1188, Vol. 68, No. 3
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Guha, M., Kumar, S., Choubey, V., Maity, P., Bandyopadhyay, U.
(2006). Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB J.
20: 1224-1226
[Abstract]
[Full Text]
-
Kassa, D., Petros, B., Mesele, T., Hailu, E., Wolday, D.
(2006). Characterization of Peripheral Blood Lymphocyte Subsets in Patients with Acute Plasmodium falciparum and P. vivax Malaria Infections at Wonji Sugar Estate, Ethiopia.. CVI
13: 376-379
[Abstract]
[Full Text]
-
KAWAI, S., IKEDA, E., SUGIYAMA, M., MATSUMOTO, J., HIGUCHI, T., ZHANG, H., KHAN, N., TOMIYOSHI, K., INOUE, T., YAMAGUCHI, H., KATAKURA, K., ENDO, K., MATSUDA, H., SUZUKI, M.
(2006). ENHANCEMENT OF SPLENIC GLUCOSE METABOLISM DURING ACUTE MALARIAL INFECTION: CORRELATION OF FINDINGS OF FDG-PET IMAGING WITH PATHOLOGICAL CHANGES IN A PRIMATE MODEL OF SEVERE HUMAN MALARIA.. Am J Trop Med Hyg
74: 353-360
[Abstract]
[Full Text]
-
Wipasa, J., Xu, H., Stowers, A., Good, M. F.
(2001). Apoptotic Deletion of Th Cells Specific for the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein 1 During Malaria Infection. J. Immunol.
167: 3903-3909
[Abstract]
[Full Text]
-
Hviid, L., Kemp;, K., Kern, P., Wellinghausen;, N., Matsumoto, J., Kawai, S., Terao, K.
(2000). What Is the Cause of Lymphopenia in Malaria?. Infect. Immun.
68: 6087-6089
[Full Text]